Andrew Saik

CIK: 0001616284

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (44.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ARVN

ARVINAS, INC.

Officer

MIST

Milestone Pharmaceuticals Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

ARVN
ARVINAS, INC.
Jun 24, 2026
Sale(S)
Direct
5.7K shares at avg. $8.16$46K
MIST
Milestone Pharmaceuticals Inc.
Jun 10, 2026
Award(A)
Stock Option (right to buy)
Direct
77K shares-
ARVN
ARVINAS, INC.
May 11, 2026
Sale(S)
Direct
11.1K shares at avg. $9.94$111K
ARVN
ARVINAS, INC.
Feb 26, 2026
Award(A)
Direct
45K shares-
ARVN
ARVINAS, INC.
Feb 13, 2026
Sale(S)
Direct
5.1K shares at avg. $11.89$61K
ARVN
ARVINAS, INC.
Jun 24, 2025
Sale(S)
Direct
5.7K shares at avg. $7.61$43K
MIST
Milestone Pharmaceuticals Inc.
Jun 10, 2025
Award(A)
Stock Option (right to buy)
Direct
40K shares-
ARVN
ARVINAS, INC.
May 9, 2025
Award(A)
Direct
59.6K shares-
ARVN
ARVINAS, INC.
Feb 13, 2025
Award(A)
Direct
49.1K shares-

		Type	Shares	Price		Ownership
Jun 24, 2026	ARVN ARVINAS, INC.	Sale(S)	5,696	$8.16	$46,474	Direct
Jun 10, 2026	MIST Milestone Pharmaceuticals Inc.	Award(A) Stock Option (right to buy)	77,000	-	-	Direct
May 11, 2026	ARVN ARVINAS, INC.	Sale(S)	11,139	$9.94	$110,693	Direct
Feb 26, 2026	ARVN ARVINAS, INC.	Award(A)	45,000	-	$0	Direct
Feb 13, 2026	ARVN ARVINAS, INC.	Sale(S)	5,134	$11.89	$61,043	Direct
Jun 24, 2025	ARVN ARVINAS, INC.	Sale(S)	5,700	$7.61	$43,377	Direct
Jun 10, 2025	MIST Milestone Pharmaceuticals Inc.	Award(A) Stock Option (right to buy)	40,000	-	-	Direct
May 9, 2025	ARVN ARVINAS, INC.	Award(A)	59,600	-	-	Direct
Feb 13, 2025	ARVN ARVINAS, INC.	Award(A)	49,092	-	-	Direct

1-9 of 9 transactions

About Saik Andrew

Saik Andrew (SEC CIK 0001616284) files insider reports with the SEC as Chief Financial Officer of ARVINAS, INC. (ARVN) and Director of Milestone Pharmaceuticals Inc. (MIST).

Signal8 holds 9 ownership filings by Saik Andrew, all Form 4s, filed between Feb 18, 2025 and Jun 24, 2026. Those filings report 9 transactions, from Feb 13, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Saik Andrew's filings is in MONTREAL.

Recent filings by Saik Andrew

Jun 24, 2026: Open-market sale of ARVN shares (Form 4, code S).
Jun 10, 2026: Grant or award of MIST derivative securities (Form 4, code A).
May 11, 2026: Open-market sale of ARVN shares (Form 4, code S).
Feb 26, 2026: Grant or award of ARVN shares (Form 4, code A).
Feb 13, 2026: Open-market sale of ARVN shares (Form 4, code S).

Other insiders filing for ARVINAS, INC. (ARVN)

How to read Form 4 transaction codes